On May 2, 2019 Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body’s immune system to fight cancer, reported that it will be presenting at the 20th Annual B. Riley FBR Institutional Investor Conference to be held May 22–23, 2019, at the Beverly Hilton Hotel in Beverly Hills, CA (Press release, Anixa Biosciences, MAY 2, 2019, View Source [SID1234535609]). Dr. Amit Kumar, Chairman, President and CEO of Anixa, will be presenting, as well as meeting with investors.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Anixa’s presentation will be live webcast at 8:30 a.m. PDT/11:30 a.m. EDT on May 23, 2019. Please register at www.wsw.com/webcast/brileyfbr3/anix to view the live webcast. A recording of the presentation will be available on Anixa’s website after the conclusion of the conference. The recording will be available for 90 days.